Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) announced a non-brokered private placement expected to raise approximately C$5 million in gross proceeds. The financing involves the issuance of 6,764,069 units at a price of C$0.7392 per unit, with each unit comprising one common share and one warrant exercisable at C$0.90 per share for a period of three years. The transaction is anticipated to close on or about July 10, 2026, subject to regulatory approvals, including that of Cboe Canada.
The company stated that the net proceeds will be allocated to advancing its ONC010 program through manufacturing and preclinical testing activities, supporting the development of its SynoGraph platform, and providing working capital for general corporate purposes. The private placement is being conducted under Canada's Listed Issuer Financing Exemption, which means the securities issued will not be subject to a hold period under applicable Canadian securities laws.
This capital infusion comes at a critical time for Onco-Innovations as it seeks to progress its proprietary technology, which targets solid tumors. The company holds an exclusive worldwide license to patented technology in oncology, and the funding will enable it to move closer to clinical development. The ONC010 program represents a key asset in the company's pipeline, and the preclinical testing and manufacturing activities are essential steps toward regulatory filings and potential human trials.
The announcement has implications for investors and the broader oncology landscape. For Onco-Innovations, the financing provides a runway to achieve important milestones without immediate dilution from a traditional offering, given the exemption from hold periods. The company's focus on solid tumors addresses a significant unmet medical need, and the SynoGraph platform could offer a novel approach to cancer treatment. The successful completion of this financing may also signal confidence from investors in the company's scientific direction and management team.
For more details, the full press release is available at https://www.nnw.fm/QatCe. Investors can also track the latest updates on the company's newsroom at https://nnw.fm/ONNVF.
